Glycodiversification for the optimization of the kanamycin class aminoglycosides

Journal of Medicinal Chemistry

Volumn 48, Issue 20, 2005, Pages 6271-6285

  Wang, Jinhua ^a   Li, Jie ^a   Chen, Hsiao Nung ^a   Chang, Huiwen ^a   Tanifum, Christabel Tomla ^a   Liu, Hsiu Hsiang ^a   Czyryca, Przemyslaw G ^a   Chang, Cheng Wei Tom ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O (3 AMINO 3,6 DIDEOXY ALPHA GLUCOPYRANOSYL)NEAMINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; KANAMYCIN B DERIVATIVE; KANAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; GLYCODIVERSIFICATION; MOLECULAR MODEL; NONHUMAN; REACTION OPTIMIZATION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; CARBOHYDRATE SEQUENCE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; KANAMYCIN; KANAMYCIN KINASE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RNA; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 26444483350     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050368c     Document Type: Article

References (36)

1. Reviews: (a) Haddad, J.; Kotra, L. P.; Mobashery, S. In Glycochemistry: Principles, Synthesis, and Applications; Wang, P. G., Bertozzi, C. R., Ed.; Marcel Dekker: New York, 2001; p307-424.
2. (b) Kondo, S. Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphyloccus aureus. Jpn. J. Antibiot. 1994, 47, 561-574.
3. (c) Vakulenko, S. B.; Mobashery, S. Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 2003, 16, 430-450.
4. (d) Hooper, I. R. Aminoglycoside Antibiotics; Springer-Verlag: New York, 1982.
5. (a) Mingeot-Leclercq, M.-P.; Glupczynski, Y.; Tulkens, P. M. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 1999, 43, 727-737.
6. (b) Kotra, L. P.; Haddad, J.; Mobashery, S. Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 2000, 44, 3249-3256.
7. (c) Wright, G. D. Aminoglycoside-modifying enzymes. Curr. Opin. Microbiol. 1999, 2, 499-503.
8. (a) Fourmy, D.; Recht, M. I.; Blanchard, S. C.; Puglisi, J. D. Structure of the A Site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 1996, 274, 1367-1371.
9. (b) Ma, C.; Baker, N. A.; Joseph, S.; McCammon, J. A. Binding of aminoglycoside antibiotics to the small ribosomal subunit: A continuum electrostatics investigation. J. Am. Chem. Soc. 2002, 124, 1438-1442.
10. (c) Fourmy, D.; Recht, M. I.; Puglisi, J. D. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16S rRNA. J. Mol. Biol. 1998, 277, 347-362.
11. (a) Fong, D. H.; Berghuis, A. M. Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J. 2002, 21, 2323-2331.
12. (b) Owston, M. A.; Serpersu, E. H. Cloning overexpression, and purification of aminoglycoside antibiotic 3-acetyltransferase-IIIb: conformational studies with bound substrates. Biochemistry 2002, 41, 10764-10770.
13. (c) Pedersen, L. C.; Benning, M. M.; Holden, H. M. Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry 1995, 34, 13305-13311.
14. (d) Cox, J. R.; McKay, G. A.; Wright, G. D.; Serpersu, E. H. Arrangement of substrates at the active site of an aminoglycoside antibiotic 3′-pohosphotransferase as determined by NMR. J. Am. Chem. Soc. 1996, 118, 1295-1301.
15. (e) Sakon, J.; Liao, H. H.; Kanikula, A. M.; Benning, M. M.; Rayment, I.; Holden, H. M. Molecular structure of kanamycin nucleotidyltransferase determined to 3.0 Å resolution. Biochemistry 1993, 32, 11977-11984.
16. (f) DiGiammarino, E. L.; Draker, K.-a.; Wright, G. D.; Serpersu, E. H. Solution studies of isepamicin and conformational comparisons between isepamicin and buritiroson A when bound to an aminoglycoside 6′-N-acetyltransferase determined by NMR spectroscopy. Biochemistry 1998, 37, 3638-3644.
17. (g) Burk, D. L.; Hon, W. C.; Leung, A. K.-W.; Berghuis, A. M. Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase. Biochemistry 2001, 40, 8756-8764.
18. For examples, see the following, (a) Tanaka, H.; Nishida, Y.; Furuta, Y.; Kobayashi, K. A convenient synthesis pathway for multivalent assembly of aminoglycoside antibiotics starting from amikacin. Bioorg. Med. Chem. Lett. 2002, 12, 1723-1726.
19. (b) Hanessian, S.; Tremblay, M.; Swayze, E. E. Tobramycin analogs with C-5 aminoalkyl ether chains intended to mimic rings III and IV of paromomycin. Tetrahedron 2003, 59, 983-993.
20. (c) Hanessian, S.; Kornienko, A.; Swayze, E. E. Probing the functional requirements of the L-haba side-chain of amikacin-synthesis, 16S A-site rRNA binding, and antibacterial activity. Tetrahedron 2003, 59, 995-1007.
21. (d) Seeberger, P. H.; Baumann, M.; Zhang, G.; Kanemitsu, T.; Swayze, E. E.; Hofstadler, S. A.; Griffey, R. H. Synthesis of neomycin analogs to investigate aminoglycoside-RNA interactions. Synlett 2003, 1323-1326.
22. (e) Chou, C.-H.; Wu, C.-S.; Chen, C.-H.; Lu, L.-D.; Kulkarni, S. S.; Wong, C.-H.; Hung, S.-C. Regioselective glycosylation of neamine core: a facile entry to kanamycin B related analogues. Org. Lett. 2004, 6, 585-588.
23. (f) Ding, Y.; Hofstadler, S. A.; Swayze, E. E.; Risen, L.; Griffey, R. H. Design and Synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay. Angew. Chem., Int. Ed. 2003, 42, 3409-3412.
24. (g) Francois, B.; Szychowski, J.; Adhikari, S. S.; Pachamuthu, K.; Swayze, E. E.; Griffey, R. H.; Migawa, M. T.; Westhof, E.; Hanessian, S. Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site. Angew. Chem., Int. Ed. 2004, 43, 6735-6738.
25. (h) Fridman, M.; Belakhov, V.; Lee, L. V.; Liang, F.-S.; Wong, C.-H.; Baasov, T. Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor. Angew. Chem., Int. Ed. 2005, 44, 447-452.
26. (i) Fridman, M.; Belakhov, V.; Yaron, S.; Baasov, T. A new class of branched aminoglycosides: Pseudo-pentasaccharide derivatives of neomycin B. Org, Lett. 2003, 5, 3575-3578.
27. (j) Liang, F.-S.; Wang, S.-K.; Nakatani, T.; Wong, C.-H. Targeting RNAs with tobramycin analogues. Angew. Chem., Int. Ed. 2004, 43, 6496-6500.
28. (k) Agnelli, F.; Sucheck, S. J.; Marby, K. A.; Rabuka, D.; Yao, S.-L.; Sears, P. S.; Liang, F.-S.; Wong, C.-H. Dimeric aminoglycosides as antibiotics. Angew. Chem., Int. Ed. 2004, 43, 1562-1566.
29. (l) Bryan, M. C.; Wong, C.-H. Aminoglycoside array for the high-throughput analysis of small molecule-RNA interactions. Tetrahedron Lett. 2004, 45, 3639-3642.
30. Elchert, B.; Li, J.; Wang, J.; Hui, Y.; Rai, R.; Ptak, R.; Ward, P.; Takemoto, J. Y.; Bensaci, M.; Chang, C.-W. T. Application of the synthetic aminosugars for glycodiversification: Synthesis and antimicrobial studies of pyranmycin. J. Org. Chem. 2004, 69, 1513-1523.
31. Li, J.; Wang, J.; Czyryca, P. G.; Chang, H.; Orsak, T. W.; Evanson, R.; Chang, C.-W. T. Application of glycodiversification: Expedient synthesis and antibacterial evaluation of a library of kanamycin B analogs. Org. Lett. 2004, 6, 1381-1384.
32. 2-catalyzed preparation of per-O-acetylated hexopyranoses with stoichiometric acetic anhydride and sequential one-pot anomeric substitution to thioglycosides under solvent-free conditions. J. Org. Chem. 2003, 68, 8719-8722.
33. Garegg, P. J. In Preparative Carbohydrate Chemistry; Hanessian, S., Ed.; Marcel Dekker: New York, 1997; pp 53-67.
34. Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria That Grow Aerobically (Approved Standard M7-A5) and Performance Standards for Antimicrobial Disk Susceptibility Tests (Approved Standard M2-A7); National Committee for Clinical Laboratory Standards: Wayne, PA.
35. One resistant strain is E. coli (TG1) equipped with the pTZ19U-3 plasmid encoded for APH(3′)-I. The other resistant strain is E. coli (TG1) equipped with the pSF815 plasmid encoded for AAC-(6′) and APH(2″).
36. The structure is based on PDB 1L8U with bound neomycin B and ADP: Fong, D. H.; Berghuis, A. M. Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J. 2002, 21, 2323-2331.